Triplet pregnancy in a Jehovah's Witness: recombinant human erythropoietin and iron supplementation for minimising the risks of excessive blood loss
2002; Wiley; Volume: 109; Issue: 6 Linguagem: Inglês
10.1111/j.1471-0528.2002.01122.x
ISSN1471-0528
AutoresEmmanuel Kalu, Christopher Wayne, Carolyn Croucher, I. Findley, Isaac Manyonda,
Tópico(s)Hemoglobinopathies and Related Disorders
ResumoBJOG: An International Journal of Obstetrics & GynaecologyVolume 109, Issue 6 p. 723-725 Triplet pregnancy in a Jehovah's Witness: recombinant human erythropoietin and iron supplementation for minimising the risks of excessive blood loss Emmanuel Kalu, Emmanuel Kalu Department of Obstetrics and Anaesthesia, St George's Healthcare NHS Trust, London, UKSearch for more papers by this authorChristopher Wayne, Christopher Wayne Department of Obstetrics and Anaesthesia, St George's Healthcare NHS Trust, London, UKSearch for more papers by this authorCarolyn Croucher, Carolyn Croucher Department of Obstetrics and Anaesthesia, St George's Healthcare NHS Trust, London, UKSearch for more papers by this authorInger Findley, Inger Findley Department of Obstetrics and Anaesthesia, St George's Healthcare NHS Trust, London, UKSearch for more papers by this authorIsaac Manyonda, Isaac Manyonda Department of Obstetrics and Anaesthesia, St George's Healthcare NHS Trust, London, UKSearch for more papers by this author Emmanuel Kalu, Emmanuel Kalu Department of Obstetrics and Anaesthesia, St George's Healthcare NHS Trust, London, UKSearch for more papers by this authorChristopher Wayne, Christopher Wayne Department of Obstetrics and Anaesthesia, St George's Healthcare NHS Trust, London, UKSearch for more papers by this authorCarolyn Croucher, Carolyn Croucher Department of Obstetrics and Anaesthesia, St George's Healthcare NHS Trust, London, UKSearch for more papers by this authorInger Findley, Inger Findley Department of Obstetrics and Anaesthesia, St George's Healthcare NHS Trust, London, UKSearch for more papers by this authorIsaac Manyonda, Isaac Manyonda Department of Obstetrics and Anaesthesia, St George's Healthcare NHS Trust, London, UKSearch for more papers by this author First published: 22 December 2003 https://doi.org/10.1111/j.1471-0528.2002.01122.xCitations: 10 *Dr I. Manyonda, Department of Obstetrics and Gynaecology, First Floor Lanesborough Wing, St George's Healthcare NHS Trust, Blackshaw Road, London SW17 0QT, UK. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 B-Lynch C, Coker A, Lawal AH, Abu J, Cowen MJ. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. Br J Obstet Gynaecol 1997; 104: 372–375. 2 Levine E, Gould S, Rosen A, et al. Perioperative recombinant human erythropoietin. Surgery 1989; 106: 432–437. 3 Levine E, Rosen A, Sehgal L, Gould S, Seghal H, Moss G. Accelerated erythropoiesis: the hidden benefit of autologous donation. Transfusion 1990; 30: 295–297. 4 Cazzolla M, Mercuriali F, Brugnara C. Use of recombinant erythropoietin outside the setting of uremia. Blood 1997; 89: 4248–4267. 5 Breyman C, Zimmermann R, Huch R, Huch A. Use of recombinant erythropoietin in combination with parenteral iron in the treatment of postpartum anemia. Eur J Clin Invest 1996; 23: 123–126. 6 Breyman C, Richter R, Huttner C, Huch R, Huch A. Effectiveness of recombinant human erythropoietin and iron sucrose vs iron therapy only in patients with postpartum anemia and blunted erythropoiesis. Eur J Clin Invest 2000; 30: 154–161. 7 Biesma D, Marx J, Kraaijenhagen R, Franke W, Messinger D, Van de Wiel A. Lower homologous blood requirement in autologous donors after treatment with recombinant human erythropoietin. Lancet 1994; 344: 367–370. 8 Rohling RG, Haers P, Zimmerman AP, Schanz U, Marquetand R, Sailer H. Multimodal strategy for reduction of homologous transfusions in cranio-maxillofacial surgery. Int J Oral Maxillofac Surg 1999; 28: 137–142. 9 MacDougal I, Hutton R, Cavill I, Coles G, Williams J. Poor response to treatment of renal anemia with erythropoietin corrected by iron given intravenously. BMJ 1989; 299: 157–158. 10 Goodnough L, Price T, Rudnick S. Iron-restricted erythropoiesis as a limitation to autologous blood donation in the erythropoietin-stimulated bone marrow. J Lab Clin Med 1991; 118: 289–296. 11 Biesma D, Kraaijhagen R, Poortman J, Marx J, van de Wiel A. The effect of oral iron supplementation on erythropoiesis in autologous blood donors. Transfusion 1992; 32: 162–165. 12 Brugnara C, Colella G, Cremins J, et al. Effects of subcutaneous recombinant erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. J Lab Clin Med 1994; 123: 660–667. 13 Rohling RG, Zimmermann AP, Breyman C. Intravenous versus oral supplementation for preoperative stimulation of hemoglobin synthesis using recombinant human erythropoietin. J Hematol Stem Cell Res 2000; 9: 497–500. 14 Van Wyck DB, Cavallo G, Spinowitz BS, et al. Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American Clinical Trial. Am J Kid Dis 2000; 36: 88–97. 15 MacDougal IC, Chandler G, Elston O, Harchowal J. Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unit. Am J Kid Dis 1999; 34(Suppl): 40–46. Citing Literature Volume109, Issue6June 2002Pages 723-725 ReferencesRelatedInformation
Referência(s)